MedicalSystem Biotechnology Co Ltd
SZSE:300439
Wall Street
Price Targets
Price Targets Summary
MedicalSystem Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for MedicalSystem Biotechnology Co Ltd is 24 CNY .
Price Targets
Revenue
Forecast
Revenue Estimate
MedicalSystem Biotechnology Co Ltd
For the last 8 years the compound annual growth rate for MedicalSystem Biotechnology Co Ltd's revenue is 14%. The projected CAGR for the next 7 years is -10%.
Operating Income
Forecast
Operating Income Estimate
MedicalSystem Biotechnology Co Ltd
For the last 8 years the compound annual growth rate for MedicalSystem Biotechnology Co Ltd's operating income is 6%. The projected CAGR for the next 7 years is -3%.
Net Income
Forecast
Net Income Estimate
MedicalSystem Biotechnology Co Ltd
For the last 8 years the compound annual growth rate for MedicalSystem Biotechnology Co Ltd's net income is 6%. The projected CAGR for the next 7 years is -2%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MedicalSystem Biotechnology Co Ltd's stock price target?
Price Target
24
CNY
According to Wall Street analysts, the average 1-year price target for MedicalSystem Biotechnology Co Ltd is 24 CNY .
What is MedicalSystem Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
-10%
For the last 8 years the compound annual growth rate for MedicalSystem Biotechnology Co Ltd's revenue is 14%. The projected CAGR for the next 7 years is -10%.
What is MedicalSystem Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
-3%
For the last 8 years the compound annual growth rate for MedicalSystem Biotechnology Co Ltd's operating income is 6%. The projected CAGR for the next 7 years is -3%.
What is MedicalSystem Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
-2%
For the last 8 years the compound annual growth rate for MedicalSystem Biotechnology Co Ltd's net income is 6%. The projected CAGR for the next 7 years is -2%.